ESC 365 - Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.

HFA Premium Access

Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.

Session: New therapeutic approaches for heart failure

Topic: Heart Failure

Speaker: Miss A. Linders (Groningen, NL)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Miss Annet Nicole Linders

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

4 more presentations in this session

Repurposing of glatiramer acetate to treat cardiac ischemia

Speaker: Doctor G. Aviel (Rehovot, IL)

FXa promotes endothelial dysfunction and pro-remodeling responses in atrial endothelial cells involving PAR1 and 2 and AT1R/NADPH oxidase/SGLT1/2 pro-oxidant pathways

Speaker: Ms W. Fakih (Strasbourg, FR)

Living myocardial slices for the study of nucleic acid-based therapies

Speaker: Doctor R. Nunez-Toldra (London, GB)

Identification and characterization of small-molecule ERBB4 agonists as a treatment for heart failure

Speaker: Miss E. Feyen (Antwerp, BE)

Access the full session

New therapeutic approaches for heart failure

Speakers: Miss A. Linders, Doctor G. Aviel, Ms W. Fakih, Doctor R. Nunez-Toldra, Miss E. Feyen

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources